| AEREA Y POSTAL EX-IAAC | 2025 | 0.02 | KG | CLOMIPRAMINA CLORHIDRATO, BP, S/M clomipramine hydrochloride 100 MG ESTANDAR PARA ANALISIS EN LABORATORIO PRESNTACION: 1 VIAL X 100 MG, UN3077 BATCH: 3815 | UNITED KINGDOM | UNITED KINGDOM | 154.44 |
| AEREA Y POSTAL EX-IAAC | 2025 | 8 | KG | (4-(3,5-bis(2-hydroxy-phenyl)-1h-1,2,4-triazol-1-yl)benzoic acid), S/M, S/M (4-(3,5-bis(2-hydroxy-phenyl)-1h-1,2,4-triazol-1-yl)benzoic acid) MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | INDIA | INDIA | 9962.75 |
| AEREA Y POSTAL EX-IAAC | 2025 | 50 | KG | (2RS)-1-(9H-CARBAZOL-4-YLOXY)-3-([2-(-2-METHOXYPHENOXY)ETHYL]AMINO]PROPAN-2-OL., S/M, S/M (2RS)-1-(9H-CARBAZOL-4-YLOXY)-3-([2-(-2-METHOXYPHENOXY)ETHYL]AMINO]PROPAN-2-OL. MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOS CREDITO A | INDIA | INDIA | 13575 |
| AEREA Y POSTAL EX-IAAC | 2025 | 150 | KG | A1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-B,8-DIHYDROXY-5-1-METHYLETHYL)-3-PHENYL-4 A1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-B,8-DIHYDROXY-5-1-METHYLETHYL)-3-PHENYL-4 MATERIA PRIMA PARA LA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN | INDIA | INDIA | 20430.7 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.213 | KG | LEFLUNOMIDA COMP RELACIONADO C (USP), USP, S/M LEFLUNOMIDE RELATED COMPOUND C (10 MG) (N-(3`- TRIFLUOROMETHYLPHENYL)-5-METHYLISOXAZOLE-4- ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION: 1 VIAL X 10 MG, CODIGO: 1357067, LOTE: R120B0 | UNITED STATES | UNITED STATES | 818.67 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.044 | KG | VALSARTAN COMPUESTO RELACIONADO B (USP), USP, S/M Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2`-(1H-tetrazole-5-yl)-biphenyl-4-yl]m ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION: 10 MG, CODIGO: 1708784, LOTE: R099B0 | UNITED STATES | UNITED STATES | 1103.65 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.103 | KG | CLINDAMICINA FOSFATO P/SIST ADECUACION, USP, S/M CLINDAMICINA FOSFATO P/SIST ADECUACION Lot: R20710 Estandares primarios para analisis en laboratorio Clindamycin Phosphate System Suitability (30 mg) | UNITED STATES | UNITED STATES | 485.94 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.091 | KG | KETOROLACO COMPUEST.RELACIONADO A (USP), UPS, S/M Ketorolac Related Compound A (20 mg) (5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2 PRESENTACION: 20 MG, CODIGO: 1356315, LOTE: R152Y0 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO KETOROLA | UNITED STATES | UNITED STATES | 858.24 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.092 | KG | GRANISETRON COMP. RELACIONADO B (USP), UPS, S/M Granisetron Related Compound B (15 mg) (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl PRESENTACION: 15 MG, CODIGO: 1298128, LOTE: R127F0 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO GRANISETRO | UNITED STATES | UNITED STATES | 868.69 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.093 | KG | LEFLUNOMIDA COMPUESTO RELACIONADO C, UPS, S/M Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl) PRESENTACION: 20 MG, CODIGO: 1357056, LOTE: R12690 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO LEFLUNOMIDA | UNITED STATES | UNITED STATES | 878.2 |
| AEREA Y POSTAL EX-IAAC | 2025 | 350 | KG | L-VALINE,N-(1-OXOPENTYL)-N-[[2-(1 H-TETRAZOL-5-YL), S/M, S/M L-VALINE,N-(1-OXOPENTYL)-N-[[2-(1 H-TETRAZOL-5-YL) [1,1-BIPHENYL]-4YL]METHYL] MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOS CREDITO 90 DIAS DESDE FECHA DE FACTURA / | UNITED STATES | CHINA | 13658.5 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.089 | KG | VALSARTAN COMPUESTO RELACIONADO B (USP), UPS, S/M VALSARTAN COMPUESTO RELACIONADO B (USP) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO | UNITED STATES | UNITED STATES | 2210.39 |